Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
DISA ( (SG:532) ) has shared an update.
Digital Life Line Pte. Ltd., a subsidiary of DISA Limited, has announced the clinical deployment of its Automated Visual Acuity Test device (AVAT) at a hospital ophthalmology clinic in Hong Kong. This deployment follows a successful trial and aims to address the high prevalence of myopia in the region by optimizing clinic resources. Developed in collaboration with the National University Hospital and NUS Medicine, AVAT automates visual acuity tests, improving efficiency and freeing up clinic staff for other tasks. The device has been used successfully in various settings, demonstrating its effectiveness and efficiency compared to standard methods. This milestone marks DLL’s expansion into global markets, enhancing vision screening accessibility through automation and AI.
More about DISA
DISA Limited, incorporated in Singapore, operates in the digital safety industry through its subsidiaries, including Digital Life Line Pte. Ltd. (DLL). The company focuses on developing innovative digital solutions, particularly in the healthcare sector, to enhance operational efficiency and accessibility.
Current Market Cap: S$21.01M
Find detailed analytics on 532 stock on TipRanks’ Stock Analysis page.